[go: up one dir, main page]

PT3551181T - Tratamento compreendendo a administração oral ou gástrica de edaravona - Google Patents

Tratamento compreendendo a administração oral ou gástrica de edaravona

Info

Publication number
PT3551181T
PT3551181T PT187013032T PT18701303T PT3551181T PT 3551181 T PT3551181 T PT 3551181T PT 187013032 T PT187013032 T PT 187013032T PT 18701303 T PT18701303 T PT 18701303T PT 3551181 T PT3551181 T PT 3551181T
Authority
PT
Portugal
Prior art keywords
edaravone
oral
treatment
gastric administration
gastric
Prior art date
Application number
PT187013032T
Other languages
English (en)
Original Assignee
Treeway Tw001 B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Treeway Tw001 B V filed Critical Treeway Tw001 B V
Publication of PT3551181T publication Critical patent/PT3551181T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
PT187013032T 2017-07-06 2018-01-17 Tratamento compreendendo a administração oral ou gástrica de edaravona PT3551181T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17180087 2017-07-06

Publications (1)

Publication Number Publication Date
PT3551181T true PT3551181T (pt) 2021-01-22

Family

ID=59315414

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187013032T PT3551181T (pt) 2017-07-06 2018-01-17 Tratamento compreendendo a administração oral ou gástrica de edaravona

Country Status (1)

Country Link
PT (1) PT3551181T (pt)

Similar Documents

Publication Publication Date Title
IL268127A (en) Preparations containing adrevan for oral or gastric administration and their use for treatment
IL289650A (en) Azolopyrimidine for the treatment of cancer-related disorders
PL3618829T3 (pl) Pochodne chinazolinopirydyny do leczenia zaburzeń związanych z nowotworem
PL3634417T3 (pl) Pochodne chinazolino-pirazolowe do leczenia chorób związanych z nowotworem
PL3558455T3 (pl) Kapsułka do spożycia do leczenia zakażeń na zasadzie fototerapii
GB201804514D0 (en) Treatment of pyroptosis
EP3600374C0 (en) TREATMENT OF A RESPIRATORY INFECTION
PL3424499T3 (pl) Kompozycja farmaceutyczna do leczenia bólu neuropatycznego
GB201805100D0 (en) Treatment of sarcopenic diseases
PT3570819T (pt) Tratamento médico compreendendo a administração intestinal de edaravona
GB201707207D0 (en) Treatment of type 1 diabetes
GB201804515D0 (en) Treatment of necroptosis
HUE062092T2 (hu) Neuropátiás fájdalom kezelésére szolgáló, alacsony koncentrációjú FLT-receptorgátló
ES3049333T3 (en) Compounds for the treatment of respiratory diseases
IL252080A0 (en) Oral administration of drugs that are unstable or poorly absorbed
ZA201904655B (en) Treatment comprising oral or gastric administration of edaravone
PT3551181T (pt) Tratamento compreendendo a administração oral ou gástrica de edaravona
IL272422A (en) Methods for treating diseases of the meninges
IL287529B (en) A pharmaceutical combination that includes trazodone for the treatment of neuropathic pain
GB201809835D0 (en) Treatment of gastrointestinal disease
ZA201908255B (en) Treatment of oral candidiasis
GB201811912D0 (en) Treatment of disease
GB201811911D0 (en) Treatment of disease
GB201814764D0 (en) Pharmaceutical compositions for the treatment of proteinopathies
GB201810974D0 (en) Treatment of disease